Talk:Lists of investigational drugs
| This is the talk page for discussing improvements to the Lists of investigational drugs article. This is not a forum for general discussion of the article's subject. |
Article policies
|
| Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |
 | This article is rated List-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
| |||||||||||||||||||||
Updates needed badly
editLarge proportion of the mentioned compounds seems have dropped from research. 88.115.35.69 (talk) 02:38, 16 June 2021 (UTC)
Idiopathic Hypersomnia
editRoth Classifications: Roth Type I: Classic Type: Polysymptomatic with EDS (Excessive Daytime Sleepiness), Sleep Drunkenness, Autonomic Instability (Orthostatic Hypotension, Orthostatic Syncope, Raynaud’s Phenomenon, Headaches {Migraines and Tension Headaches), Sleep Drunkenness, Sleep Inertia, Repeat Sleep Latency Testing (RSLT), Sleep Arousal Difficulties, Prolonged Sleep (greater than 12 hours in a single sleep episode) Roth Type II: Excessive Daytime Sleepiness without associated Symptomatology Associated with the “Somnogen” Subtance found in the cerebrospinal fluid in affected patients with hypersensitivity to GABBA alpha receptors responsible for somnolence similar to someone who was given a continuous infusion of Ativan and benzodiazepine-like medications in spite of not taking any such drugs. It’s thought to be genetic, although very rare in patients without the genetic forms of narcolepsy without associated cataplexy Ruth Deerfield, M.D. (talk) 08:20, 31 January 2022 (UTC)